CellWell record HH-19390
A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease
Zhang PW; Chen FX; Li D; Ling WH; Guo HH
Medicine ยท 2015
In plain language
In a 12-week randomized placebo-controlled trial in 74 NAFLD patients, 320 mg/day purified anthocyanin from bilberry and black currant was associated with significantly lower ALT and other markers of liver injury.
- Evidence
- Established
- Design
- Randomized controlled trial
- Studied in
- Human
Cite this record: https://thecellwell.org/studies/HH-19390
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.